コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 the ischemically damaged small intestine and ascending colon.
2 ut first in the stomach, small intestine and ascending colon.
3 ein expression was significantly enhanced in ascending colon.
4 of the most proximal inflection point in the ascending colon.
5 lly, overlying the position of the cecum and ascending colon.
6 wel, and most commonly affects the cecum and ascending colon.
7 ps were created at the posterior wall of the ascending colon.
8 Right-sided colon was defined as caecum and ascending colon.
9 -41.5 months; P <.001), primary tumor in the ascending colon (17.9 months; 95% CI, 0-37.5 months; P <
10 patic flexure in 4 patients (36%), cecum and ascending colon (4 pts, 36%), rectosigmoid (2 pts, 18%)
12 ion (positive criteria); (c) air or stool in ascending colon and (d) cecal air or stool (negative cri
13 erry extract by microbiota obtained from the ascending colon and descending colon compartments of a d
14 galectins were significantly reduced in the ascending colon and duodenum in ART-treated SIV-infected
15 be divided into three major clusterings: (1) ascending colon and transverse colon, (2) descending col
21 ells are normally present in human cecum and ascending colon, but are rarely found in descending colo
23 mucosal biopsies from the terminal ileum and ascending colon during surgery and post-operative colono
25 as a significant overall treatment effect on ascending colon emptying half-time (P = .015) and overal
28 omparison of gene expression profiles in the ascending colon from a subset of patients with ASD, chro
29 nd paired biopsies of the terminal ileum and ascending colon from healthy individuals (male=3, female
31 s defined as any tumor arising in the cecum, ascending colon, hepatic flexure, or transverse colon.
32 sigmoid colon, or rectum vs appendix, cecum, ascending colon, hepatic flexure, or transverse colon.
33 sigmoid colon, or rectum vs appendix, cecum, ascending colon, hepatic flexure, or transverse colon.
34 thelial cell type in both terminal ileum and ascending colon (hereon as 'LND') with high expression o
35 ing) colon but not of the right (proximal or ascending) colon (HR = 1.03, 95% CI: 0.89, 1.18), while
36 ormal colorectal anatomical locations (i.e., ascending colon (n = 182), transverse colon (n = 249), d
37 subsites of the colorectum: cecum (n = 63), ascending colon (n = 44), transverse colon (n = 32), des
39 e of cytological dysplasia, primarily in the ascending colon (n = 6/42, 14%), Transverse colon (n = 2
40 GCPII in the 400 mug supplement group in the ascending colon, no treatment differences were observed
43 signal intensity (r = 0.88, P = .033 for the ascending colon; r = 0.82, P = .006 for the descending c
44 g sensitivities (SE) and specificities (SP) (ascending colon: SE: 1.10%, SP: 91.02; transverse colon:
45 ntent (SBWC), colonic volumes, and T1 of the ascending colon (T1AC) as measures of colonic water.
46 ering all subjects, the percentage change in ascending colon volume rose significantly after CRF.
51 ative lesions from the terminal ileum to the ascending colon with a non-specific histo-pathologic fin